Business
Broadwood Partners Files Definitive Proxy Statement Soliciting STAAR Surgical Stockholders to Vote "AGAINST" Proposed Acquisition by Alcon
NEW YORK, September 24, 2025--Broadwood Partners, L.P. and its affiliates (collectively, "Broadwood"), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) today announced that it has filed a definitive proxy statement and GREEN proxy card with the U.S. Securities and Exchange Commission (the "SEC") and sent a letter to its fellow stockholders in connection with its opposition to the proposed acquisition of the Company
About this update from Staar Surgical Company
[{"type":"text","content":"Outlines Its Belief that the Proposed Transaction Is the Product of Bad Timing, a Flawed Process, and Significant Conflicts of Interest","length":135,"tagName":"p","attribs":{}},{"type":"text","content":"Broadwood Believes the Transaction Delivers Less Value than Alternatives, Including a Properly Run Strategic Alternatives Process or Improved Execution as a Standalone Business","length":176,"tagName":"p","attribs":{}},{"type":"text","content":"Sends Letter to STAAR Stockholders","length":34,"tagName":"p","attribs":{}},{"type":"text","content":"NEW YORK, September 24, 2025--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, "Broadwood"), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) today announced that it has filed a definitive proxy statement and GREEN proxy card with the U.S. Securities and Exchange Commission (the "SEC") and sent a letter to its fellow stockholders in connection with its opposition to the proposed acquisition of the Company by an affiliate of Alcon Inc. (NYSE: ALC) on the terms announced on August 5, 2025 (the "Proposed Merger").","length":675,"tagName":"p"},{"type":"text","content":"The full text of Broadwood’s letter is below.","length":45,"tagName":"p"},{"type":"text","content":"* * *","length":5,"tagName":"p","attribs":{}},{"type":"text","content":"September 24, 2025","length":18,"tagName":"p"},{"type":"text","content":"Dear Fellow STAAR Surgical Stockholders,","length":40,"tagName":"p"},{"type":"text","content":"Broadwood Partners, L.P. and its affiliates (collectively, "Broadwood," "we," "us," or "our") have been committed investors in, and strong supporters of STAAR Surgical Company ("STAAR" or the "Company") for more than thirty years. We provided needed capital to the Company on various occasions and purchased a substantial number of additional shares over time in the public markets, including as recently as a few months ago. Today, we beneficially own approximately 27.5% of STAAR’s outstanding shares, making us the Company’s largest stockholder by a significant margin.","length":632,"tagName":"p"},{"type":"text","content":"We initially invested in STAAR, and have added to our positi...